List of SBIR/STTR awards granted to PHYLONIX PHARMACEUTICALS, INC.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $135,227.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL088790-01A1 | Phase I | 135,227 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $951,834.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA085034-02 | Phase II | 951,834 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $936,385.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DC007767-02 | Phase II | 936,385 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $202,041.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44EY016254-02 | Phase II | 202,041 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $171,237.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS050874-01 | Phase I | 171,237 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $164,499.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH082456-01 | Phase I | 164,499 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $168,689.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS058251-01A1 | Phase I | 168,689 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $993,463.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA083256-02A1 | Phase II | 993,463 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $951,875.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA090153-02 | Phase II | 951,875 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $183,849.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA112672-01 | Phase I | 183,849 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $160,671.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM083366-01 | Phase I | 160,671 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $362,566.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS048607-02 | Phase II | 362,566 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $164,366.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK074169-01 | Phase I | 164,366 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. from the U.S. Department of Health & Human Services. | SBIR | 2R44CA083256-02A1 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. from the U.S. Department of Health & Human Services. | SBIR | 2R44CA090153-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $161,810.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR055390-01 | Phase I | 161,810 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $193,979.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM087923-01 | Phase I | 193,979 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $191,984.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA150293-01 | Phase I | 191,984 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. from the U.S. Department of Health & Human Services. | SBIR | 2R44CA085034-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $169,605.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DC007767-01 | Phase I | 169,605 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $1,025,402.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA091495-02 | Phase II | 1,025,402 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $223,872.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS046811-01A1 | Phase I | 223,872 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $193,595.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM085983-01 | Phase I | 193,595 | ||||||||
A SBIR Phase II contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $1,051,400.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44ES017366-02 | Phase II | 1,051,400 | ||||||||
A SBIR Phase I contract was awarded to PHYLONIX PHARMACEUTICALS, INC. for $201,382.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM085892-01 | Phase I | 201,382 |
